Positive predictive value (PPV), sensitivity and specificity

Group 1. Women with deviations of immune reactivity in one or more parameters of ELI-P-Complex (n = 2153)

257 + 1763

133

Group 2. Women with normal results of ELI-P-Complex (n = 1816)

148

1403 + 145 + 120

Relative risk (RR) for pregnancy complications

Group 1. Women with deviations of immune reactivity in one or more parameters of ELI-P-Complex (n = 2153)

257 + 1763

28 + 105

Group 2. Women with normal results of ELI-P-Complex (n = 1816)

127 + 11 + 8

1403 + 145 + 122

Relative risk (RR) for adverse pregnancy outcome

Group 1. Women with deviations of immune reactivity in one or more parameters of ELI-P-Complex (n = 2153)

120 + 753

165 + 1115

Group 2. Women with normal results of ELI-P-Complex (n = 1816)

108 + 9 + 8

1422 + 147 + 122

Relative risk (RR) for newborns health state

Group 1. Women with deviations of immune reactivity in one or more parameters of ELI-P-Complex (n = 1549)

714 + 109

620 + 106

Group 2. Women with normal results of ELI-P-Complex (n = 1663)

87 + 12 + 12

1297 + 140 + 115